Association between transforming growth factor beta 1 and progression-free survival in breast cancer.

被引：0
|
作者：
Yang, George Ruochen [1 ]
Takita, Cristiane [1 ]
Wright, Jean L. [2 ]
Reis, Isildinha M. [1 ]
Lee, Eunkyung [3 ]
Hu, Jennifer J. [1 ]
机构：
[1] Univ Miami, Sch Med, Miami, FL USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Univ Cent Florida, Miami, FL USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
897
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Thymidylate synthase expression as a predictive factor for response and progression-free survival in metastatic breast cancer patients
    Seki, Hirohito
    Jinno, Hiromitsu
    Hayashida, Tetsu
    Takahashi, Maiko
    Kaneda, Munehisa
    Suzuki, Keiichi
    Hara, Hidenori
    Osaku, Masayoshi
    Yamada, Yoshinori
    Asamuna, Humiki
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [32] Polymorphisms in the Transforming Growth Factor Beta 1 Pathway in Relation to Colorectal Cancer Progression
    Foersti, Asta
    Li, Xuchen
    Wagner, Kerstin
    Tavelin, Bjorn
    Enquist, Kerstin
    Palmqvist, Richard
    Altieri, Andrea
    Hallmans, Goran
    Hemminki, Kari
    Lenner, Per
    GENES CHROMOSOMES & CANCER, 2010, 49 (03): : 270 - 281
  • [33] IMMUNOHISTOCHEMICAL STAINING FOR TRANSFORMING GROWTH FACTOR-BETA-1 ASSOCIATES WITH DISEASE PROGRESSION IN HUMAN BREAST-CANCER
    GORSCH, SM
    MEMOLI, VA
    STUKEL, TA
    GOLD, LI
    ARRICK, BA
    CANCER RESEARCH, 1992, 52 (24) : 6949 - 6952
  • [34] Progression-free survival with regorafenib in gastric cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (08): : E323 - E323
  • [35] Transforming growth factor-beta signaling in breast cancer
    Chang, Ching-Fang
    Westbrook, Reyhan
    Ma, Jun
    Cao, Deliang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4393 - 4401
  • [36] A deep learning-enabled workflow to estimate real world progression-free survival in patients with metastatic breast cancer.
    Varma, Gowtham
    Yenukoti, Rohit Kumar
    Kumar, Praveen M.
    Ashrit, Bandlamudi Sai
    Purushotham, K.
    Subash, C.
    Ravi, Sunil Kumar
    Kurien, Verghese
    Aman, Avinash
    Manoharan, Mithun
    Jaiswal, Shashank
    Anand, Akash
    Barve, Rakesh
    Thiagarajan, Viswanathan
    Lenehan, Patrick
    Soefje, Scott A.
    Soundararajan, Venky
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
    Mertz, Shirley
    Benjamin, Christine
    Girvalaki, Charis
    Cardone, Antonella
    Gono, Paulina
    May, Suepattra G.
    Comerford, Erin
    Than, Kyi-Sin
    Birch, Kelly
    Roach, Meaghan
    Myers, Sky
    Sasane, Medha
    Lavi, Liat
    Cameron, Anna
    Cardoso, Fatima
    BREAST, 2022, 65 : 84 - 90
  • [38] Modelling of overall survival by an association between progression-free and post-progression survival using a conditional distribution
    Belkacemi, Mohamed C.
    Castelli, Christel
    Remita, Mohamed R.
    Fournel, Pierre
    Daures, Jean P.
    STATISTICAL MODELLING, 2014, 14 (01) : 77 - 98
  • [39] Trastuzumab prolongs progression-free survival in hormone-dependent and HER2-positive metastatic breast cancer.
    Mackey, J. R.
    Kaufman, B.
    Clemens, M.
    Bapsy, P. P.
    Vaid, A.
    Wardley, A.
    Tjulandin, S.
    Jahn, M.
    Lehle, M.
    Jones, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S5 - S6
  • [40] Elevated Serum Ferritin Predicts Reduced Progression-Free and Overall Survival in Trastuzumab-Treated Metastatic Breast Cancer.
    Alkhateeb, A. A.
    Connor, J.
    Leitzel, K.
    Ali, S.
    Campbell-Baird, C.
    Evans, M.
    Koestler, W.
    Fuchs, E-M
    Lipton, A.
    CANCER RESEARCH, 2011, 71
12345